Overview
Scott Gitlin is a Hematologist in Ann Arbor, Michigan. Dr. Gitlin is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Hemangioma Thrombocytopenia Syndrome.
His clinical research consists of co-authoring 21 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
Locations
1500 E Medical Ctr, Suite 0331, Ann Arbor, MI 48109
1500 E Medical Ctr Dr, Ann Arbor, MI 48109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Regents Of The University Of Michigan
Erica Campagnaro is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Campagnaro is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is currently accepting new patients.
Regents Of The University Of Michigan
Matthew Pianko is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Pianko is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma, and Bone Marrow Transplant. Dr. Pianko is currently accepting new patients.
Regents Of The University Of Michigan
Asra Ahmed is a Hematologist in Ann Arbor, Michigan. Dr. Ahmed is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Reticulohistiocytoma, Histiocytosis, Non-Langerhans-Cell Histiocytosis, Rosai-Dorfman Disease, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adult Immune ThrombocytopeniaDr. Gitlin isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Autoimmune Hemolytic AnemiaDr. Gitlin isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Hemangioma Thrombocytopenia Syndrome
- Hemophagocytic Lymphohistiocytosis
- Immune Thrombocytopenic Purpura (ITP)
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Experienced
- Acquired AgranulocytosisDr. Gitlin isExperienced. Learn about Acquired Agranulocytosis.
- Acute Hepatic Porphyria (AHP)Dr. Gitlin isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Intermittent PorphyriaDr. Gitlin isExperienced. Learn about Acute Intermittent Porphyria.
- AgranulocytosisDr. Gitlin isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Gitlin isExperienced. Learn about Anemia.
- Antiphospholipid SyndromeDr. Gitlin isExperienced. Learn about Antiphospholipid Syndrome.